Showing results (121-130 of 388) with videos related to
Sort By:
Pageof 39
European Journal of Nuclear Medicine and Molecular Imaging|January 12, 2008
Report on short-term side effects of treatments with 177Lu-octreotate in combination with capecitabine in seven patients with gastroenteropancreatic neuroendocrine tumoursMartijn van Essen, Eric P Krenning, Boen L Kam, et al.Annals of Surgery|November 23, 2000
Endoscopic retroperitoneal adrenalectomy: lessons learned from 111 consecutive casesH J Bonjer, V Sorm, F J Berends, et al.European Journal of Nuclear Medicine and Molecular Imaging|January 30, 2007
Peptide receptor radionuclide therapy with 177Lu-octreotate in patients with foregut carcinoid tumours of bronchial, gastric and thymic originMartijn van Essen, Eric P Krenning, Willem H Bakker, et al.European Journal of Endocrinology|August 14, 2014
GEPNETs update: Radionuclide therapy in neuroendocrine tumorsWouter A van der Zwan, Lisa Bodei, Jan Mueller-Brand, et al.Nederlands Tijdschrift Voor Geneeskunde|July 13, 1996
[Cushing's disease: successful surgery through improved preoperative tumor localization]M O van Aken, R Singh, J H van den Berge, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2010
Salvage therapy with (177)Lu-octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumorsMartijn van Essen, Eric P Krenning, Boen L R Kam, et al.Clinical Endocrinology|August 1, 1997
Postoperative metyrapone test in the early assessment of outcome of pituitary surgery for Cushing's diseaseM O van Aken, W W de Herder, A J van der Lely, et al.The Journal of Clinical Endocrinology and Metabolism|September 16, 1999
Interferon-alpha-2a is a potent inhibitor of hormone secretion by cultured human pituitary adenomasL J Hofland, W W de Herder, M Waaijers, et al.Acta Endocrinologica|July 1, 1993
Current tools in the diagnosis of pituitary tumoursS W Lamberts, W W de Herder, D J Kwekkeboom, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2004
Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic systemK Oberg, L Kvols, M Caplin, et al.Pageof 39